The session delves into the intricate links between obesity and liver health, with a particular emphasis on non-alcoholic fatty liver disease (NAFLD) and the development of hepatic fibrosis. Attendees will examine the underlying mechanisms, key risk factors, and the progression of liver pathology in individuals with obesity. The discussion extends to practical, evidence-based approaches for early detection, lifestyle modification, and clinical management—tools crucial for preventing fibrosis and improving long-term patient outcomes. Through case studies and the latest research, healthcare professionals will gain actionable insights for managing the real-world challenges posed by obesity-related liver complications.
Connect, collaborate, and contribute to driving excellence in obesity research, clinical practice, and public health approaches globally.
